Zolpidem tartrate 3.5 MG Sublingual Tablet — RxCUI 1232202
RxNorm drug concept · Semantic clinical drug
RxCUI 1232202
Semantic clinical drug · SCD
● Current RxNorm concept 4 FDA products
4 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1232202
Official nameZolpidem tartrate 3.5 MG Sublingual Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped4
Package NDCs mapped4
Reported Medicaid activity (SDUD)235 prescriptions · 4 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Zolpidem: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Zolpidem treats insomnia. Depending on the product, it helps you fall asleep, stay asleep, or get back to sleep after waking in the middle of the night. Most are meant for short-te...
- Take it right at bedtime, only when you can get a full 7 to 8 hours of sleep. Try not to take it with or right after a meal, since food can slow it down. Swallow extended-release t...
- No, please avoid it. Alcohol adds to drowsiness and can make your coordination and alertness worse. The same goes for other sedating medicines, so tell me everything you take.
- Zolpidem can cause next-day impairment even when you feel fine. Avoid driving or anything that needs full alertness if you took more than directed, had less than a full night to sl...
🕸️ Concept Web — How Zolpidem tartrate 3.5 MG Sublingual Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Zolpidem tartrate 3.5 MG Sublingual Tablet
RxCUI 1232202 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Zolpidem
39993IN -
Zolpidem tartrate
221183PIN
-
Zolpidem
-
Dose forms 12
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Zolpidem Sublingual Tablet
836640SCDF -
Zolpidem tartrate Sublingual Tablet
2648741SCDFP -
Zolpidem Oral Product
1156259SCDG -
Zolpidem Pill
1156260SCDG -
Zolpidem Sublingual Product
1295635SCDG -
Zolpidem tartrate Oral Product
2660744SCDGP -
Zolpidem tartrate Pill
2661550SCDGP -
Zolpidem tartrate Sublingual Product
2661852SCDGP - +4 more in this family
-
Zolpidem Sublingual Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Zolpidem tartrate 3.5 MG
1232201SCDC
-
Zolpidem tartrate 3.5 MG
Showing up to 8 concepts per family — 11 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Zolpidem tartrate 3.5 MG
SCDC · 1232201 -
Zolpidem Sublingual Tablet
SCDF · 836640 -
Zolpidem tartrate Sublingual Tablet
SCDFP · 2648741 -
Zolpidem Oral Product
SCDG · 1156259 -
Zolpidem Pill
SCDG · 1156260 -
Zolpidem Sublingual Product
SCDG · 1295635 -
Zolpidem tartrate Oral Product
SCDGP · 2660744 -
Zolpidem tartrate Pill
SCDGP · 2661550 -
Zolpidem tartrate Sublingual Product
SCDGP · 2661852
📦 FDA Products & Package NDCs
4 products · 4 package NDCs
4 package NDCs map to RxCUI 1232202 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 43386-0761-30 | 30 POUCH in 1 CARTON (43386-761-30) / 1 BLISTER PACK in 1 P... | ZOLPIDEM TARTRATE | Lupin Pharmaceuticals,Inc. | 2016-03-22 |
| 43386-0762-30 | 30 POUCH in 1 CARTON (43386-762-30) / 1 BLISTER PACK in 1 P... | ZOLPIDEM TARTRATE | Lupin Pharmaceuticals,Inc. | 2016-03-22 |
| 49884-0898-11 | 30 POUCH in 1 CARTON (49884-898-11) / 1 TABLET in 1 POUCH (... | Zolpidem tartrate sublingual | Par Health USA, LLC | 2017-09-11 |
| 49884-0899-11 | 30 POUCH in 1 CARTON (49884-899-11) / 1 TABLET in 1 POUCH (... | Zolpidem tartrate sublingual | Par Health USA, LLC | 2017-09-11 |
Observed labelers:
Lupin Pharmaceuticals,Inc. (2) ·
Par Health USA, LLC (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.